Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

A profile of Dr. Ted Love, GBT’s CEO, by Haverford College Magazine (pdf)

Recent News

08/09/17Global Blood Therapeutics Announces Participation at the 2017 Wedbush PacGrow Healthcare Conference
08/07/17Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial Results
07/26/17Global Blood Therapeutics Announces New Employment Inducement Grants
07/10/17Global Blood Therapeutics Expands Ongoing Phase 2a HOPE-KIDS 1 Study into Younger Pediatric Population

More »

Media Resources

Media Contact

Julie Normart